Connect
← Return to New alternative to Paxlovid seems to prevent Long Covid in mice
Discussion
New alternative to Paxlovid seems to prevent Long Covid in mice
Post-COVID Recovery & COVID-19 | Last Active: Jun 5 7:29pm | Replies (4)Comment receiving replies
I took Paxlovid after my first bout with Covid in 2022. It is a dreadful medication that makes your mouth taste like a garbage can. It did not prevent Covid-related heart problems, high blood pressure and hearing loss which happened about a month after I tested negative for Covid.
The next time I got Covid a few months later, I declined to take Paxlovid again. This time I took
Lagevrio (molnupiravir). It worked much better and I didn't have any extra problems.
Lagevrio (molnupiravir) actually came on the market before Paxlovid and I can only guess more aggressive marketing gave Paxlovid the edge.
Replies to "I took Paxlovid after my first bout with Covid in 2022. It is a dreadful medication..."
Connect
That's interesting about molnupiravir! I looked it up, and as you say, it definitely is an alternative to Paxlovid.
And "Garbage Can Mouth" sounds rather off-putting!
If I catch Covid for the second time (and I just got, like, my eighth booster), I think I will get my doctor to prescribe it.
Plus, apparently, there is such a thing as "Paxlovid rebound", although perhaps this might happen with molnupiravir, too.
(God, there are so many variables at play with this illness, aren't there?)
But thanks very much for that info!